- Home
- NVCT vs QTRX Comparison
NVCT vs QTRX Comparison
Compare NVCT & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCT
- QTRX
- Stock Information
- Founded
- NVCT 2020
- QTRX 2007
- Country
- NVCT United States
- QTRX United States
- Employees
- NVCT N/A
- QTRX N/A
- Industry
- NVCT Medicinal Chemicals and Botanical Products
- QTRX Biotechnology: Laboratory Analytical Instruments
- Sector
- NVCT Health Care
- QTRX Industrials
- Exchange
- NVCT Nasdaq
- QTRX Nasdaq
- Market Cap
- NVCT 170.3M
- QTRX 201.7M
- IPO Year
- NVCT 2022
- QTRX 2017
- Fundamental
- Price
- NVCT $8.87
- QTRX $5.15
- Analyst Decision
- NVCT Strong Buy
- QTRX Strong Buy
- Analyst Count
- NVCT 3
- QTRX 4
- Target Price
- NVCT $15.67
- QTRX $18.25
- AVG Volume (30 Days)
- NVCT 128.2K
- QTRX 764.8K
- Earning Date
- NVCT 05-06-2025
- QTRX 05-06-2025
- Dividend Yield
- NVCT N/A
- QTRX N/A
- EPS Growth
- NVCT N/A
- QTRX N/A
- EPS
- NVCT N/A
- QTRX N/A
- Revenue
- NVCT N/A
- QTRX $137,421,000.00
- Revenue This Year
- NVCT N/A
- QTRX $5.22
- Revenue Next Year
- NVCT N/A
- QTRX $15.31
- P/E Ratio
- NVCT N/A
- QTRX N/A
- Revenue Growth
- NVCT N/A
- QTRX 12.30
- 52 Week Low
- NVCT $4.44
- QTRX $4.67
- 52 Week High
- NVCT $11.80
- QTRX $19.18
- Technical
- Relative Strength Index (RSI)
- NVCT 51.36
- QTRX 36.29
- Support Level
- NVCT $8.70
- QTRX $5.03
- Resistance Level
- NVCT $10.19
- QTRX $5.73
- Average True Range (ATR)
- NVCT 0.93
- QTRX 0.52
- MACD
- NVCT -0.08
- QTRX -0.02
- Stochastic Oscillator
- NVCT 40.45
- QTRX 21.43
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.